Human Genome Sciences 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 16, 2012
HUMAN GENOME SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code: (301) 309-8504
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Section 5 Corporate Governance and Management
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 16, 2012, Human Genome Sciences, Inc. (the Company) held its annual meeting of stockholders (the Annual Meeting). The proxy statement pertaining to the Annual Meeting was previously filed by the Company with the Securities and Exchange Commission on March 30, 2012. As of the close of business on the record date of March 23, 2012, there were 199,102,958 shares of common stock outstanding and entitled to vote. The tabulation of votes for each proposal voted on by stockholders was as follows:
Proposal 1: Election of Directors.
Proposal 2: Ratification of the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for 2012.
Proposal 3: Advisory vote on the compensation paid to the named executive officers.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 16, 2012